Microbix Biosystems Inc. MBX.TO
Health Care · Pharmaceuticals, Biotechnology & Life Sciences · TSX · Canada · microbix.com
Microbix Biosystems Inc. is a Canadian life science company that develops and commercializes proprietary biological and technological solutions for human health and wellbeing. The company manufactures infectious disease antigens, external quality control materials (QAPs brand), viral transport medium (DxTM brand), and Kinlytic, a biologic thrombolytic drug used to treat blood clots, serving the global diagnostics industry. Headquartered in Mississauga, Canada, Microbix ships products to all seven continents.
Key ratios
FreeCashFlowOnSale TTM -0.25
FreeCashFlowOnSale 2025 -0.05
FreeCashFlowOnSale 2024 0.11
FreeCashFlowOnSale 2023 -0.13
NetIncomeMargin TTM -0.25
NetIncomeMargin 2025 -0.12
NetIncomeMargin 2024 0.14
NetIncomeMargin 2023 -0
ReturnOnAssets TTM -0.06
ReturnOnAssets 2025 -0.03
ReturnOnAssets 2024 0.07
ReturnOnAssets 2023 -0.05
ReturnOnEquity TTM -0.15
ReturnOnEquity 2025 -0.08
ReturnOnEquity 2024 0.13
ReturnOnEquity 2023 -0
Recent news
Microbix Reports Results for H1 & Q2 2026
2026-05-14 · Globe and Mail
Microbix Product Results Being Presented at 2026 PASCV
2026-04-27 · BioSpace